SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2015 -- AMPE

NEW YORK, July 1, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Ampio Pharmaceuticals, Inc. ("Ampio Pharmaceuticals") AMPE between January 13, 2014 and August 21, 2014.

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. If you purchased or otherwise acquired Ampio Pharmaceuticals shares between January 13, 2014 and August 21, 2014, your rights may be affected by this action. To get more information go to:

http://zlk.9nl.com/ampiopharmaceuticals

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that the Company failed to disclose that the clinical research organization conducting the Company's STEP Study lacked independence and that the trial drug supply for the STEP study was shipped to clinical sites at lower temperatures than permitted by the drug specifications.

If you suffered a loss in Ampio Pharmaceuticals you have until July 7, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.